nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—HDAC1—manus—leprosy	0.0637	0.114	CbGeAlD
Vorinostat—HDAC1—manual digit—leprosy	0.0624	0.111	CbGeAlD
Vorinostat—HDAC1—Menadione—Thalidomide—leprosy	0.0325	0.855	CbGdCrCtD
Vorinostat—HDAC11—eye—leprosy	0.0245	0.0436	CbGeAlD
Vorinostat—Thromboembolism—Thalidomide—leprosy	0.024	0.0802	CcSEcCtD
Vorinostat—NCOR1—skin of body—leprosy	0.0206	0.0368	CbGeAlD
Vorinostat—HDAC1—eye—leprosy	0.019	0.0339	CbGeAlD
Vorinostat—HDAC9—eye—leprosy	0.0187	0.0334	CbGeAlD
Vorinostat—HDAC8—tendon—leprosy	0.0186	0.0331	CbGeAlD
Vorinostat—HDAC3—skin of body—leprosy	0.0181	0.0322	CbGeAlD
Vorinostat—HDAC4—tendon—leprosy	0.018	0.0322	CbGeAlD
Vorinostat—HDAC6—testis—leprosy	0.0173	0.0309	CbGeAlD
Vorinostat—HDAC6—nervous system—leprosy	0.017	0.0303	CbGeAlD
Vorinostat—Proteinuria—Dapsone—leprosy	0.017	0.0567	CcSEcCtD
Vorinostat—Protein urine present—Dapsone—leprosy	0.0167	0.0559	CcSEcCtD
Vorinostat—HDAC1—skin of body—leprosy	0.0166	0.0295	CbGeAlD
Vorinostat—HDAC8—testis—leprosy	0.0154	0.0274	CbGeAlD
Vorinostat—Embolism venous—Thalidomide—leprosy	0.0151	0.0505	CcSEcCtD
Vorinostat—HDAC4—testis—leprosy	0.0149	0.0266	CbGeAlD
Vorinostat—HDAC4—nervous system—leprosy	0.0147	0.0261	CbGeAlD
Vorinostat—HDAC3—tendon—leprosy	0.0138	0.0245	CbGeAlD
Vorinostat—HDAC11—testis—leprosy	0.0134	0.0239	CbGeAlD
Vorinostat—HDAC11—nervous system—leprosy	0.0132	0.0235	CbGeAlD
Vorinostat—NCOR1—testis—leprosy	0.013	0.0232	CbGeAlD
Vorinostat—NCOR1—nervous system—leprosy	0.0128	0.0228	CbGeAlD
Vorinostat—HDAC1—tendon—leprosy	0.0126	0.0225	CbGeAlD
Vorinostat—Deep vein thrombosis—Thalidomide—leprosy	0.0126	0.0419	CcSEcCtD
Vorinostat—Serum creatinine increased—Thalidomide—leprosy	0.0124	0.0415	CcSEcCtD
Vorinostat—HDAC9—tendon—leprosy	0.0124	0.0221	CbGeAlD
Vorinostat—NR0B1—testis—leprosy	0.0122	0.0218	CbGeAlD
Vorinostat—Embolism—Thalidomide—leprosy	0.0119	0.0397	CcSEcCtD
Vorinostat—HDAC3—testis—leprosy	0.0114	0.0203	CbGeAlD
Vorinostat—HDAC3—nervous system—leprosy	0.0112	0.0199	CbGeAlD
Vorinostat—HDAC1—testis—leprosy	0.0104	0.0186	CbGeAlD
Vorinostat—HDAC9—testis—leprosy	0.0103	0.0183	CbGeAlD
Vorinostat—HDAC1—nervous system—leprosy	0.0103	0.0183	CbGeAlD
Vorinostat—HDAC9—nervous system—leprosy	0.0101	0.018	CbGeAlD
Vorinostat—HDAC2—eye—leprosy	0.00958	0.0171	CbGeAlD
Vorinostat—Proteinuria—Thalidomide—leprosy	0.00869	0.029	CcSEcCtD
Vorinostat—Protein urine present—Thalidomide—leprosy	0.00857	0.0286	CcSEcCtD
Vorinostat—HDAC2—skin of body—leprosy	0.00833	0.0148	CbGeAlD
Vorinostat—Pulmonary embolism—Thalidomide—leprosy	0.00764	0.0255	CcSEcCtD
Vorinostat—HDAC3—Validated targets of C-MYC transcriptional repression—SLC11A1—leprosy	0.00716	0.0707	CbGpPWpGaD
Vorinostat—Sepsis—Thalidomide—leprosy	0.00663	0.0221	CcSEcCtD
Vorinostat—HDAC2—tendon—leprosy	0.00634	0.0113	CbGeAlD
Vorinostat—Dermatitis exfoliative—Thalidomide—leprosy	0.00587	0.0196	CcSEcCtD
Vorinostat—Cough—Dapsone—leprosy	0.00569	0.019	CcSEcCtD
Vorinostat—Lethargy—Thalidomide—leprosy	0.00566	0.0189	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00554	0.0185	CcSEcCtD
Vorinostat—HDAC2—Menadione—Thalidomide—leprosy	0.00552	0.145	CbGdCrCtD
Vorinostat—HDAC1—Validated targets of C-MYC transcriptional repression—SLC11A1—leprosy	0.00537	0.053	CbGpPWpGaD
Vorinostat—HDAC2—testis—leprosy	0.00525	0.00936	CbGeAlD
Vorinostat—Blood creatinine increased—Thalidomide—leprosy	0.00519	0.0173	CcSEcCtD
Vorinostat—Dehydration—Thalidomide—leprosy	0.00515	0.0172	CcSEcCtD
Vorinostat—HDAC2—nervous system—leprosy	0.00515	0.00918	CbGeAlD
Vorinostat—Hypokalaemia—Thalidomide—leprosy	0.00504	0.0168	CcSEcCtD
Vorinostat—Pancytopenia—Thalidomide—leprosy	0.00455	0.0152	CcSEcCtD
Vorinostat—HDAC1—Apoptosis-related network due to altered Notch3 in ovarian cancer—RIPK2—leprosy	0.00449	0.0443	CbGpPWpGaD
Vorinostat—Neutropenia—Thalidomide—leprosy	0.00448	0.015	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Thalidomide—leprosy	0.00445	0.0149	CcSEcCtD
Vorinostat—Weight decreased—Thalidomide—leprosy	0.00433	0.0145	CcSEcCtD
Vorinostat—Hyperglycaemia—Thalidomide—leprosy	0.00432	0.0144	CcSEcCtD
Vorinostat—HDAC3—p75 NTR receptor-mediated signalling—RIPK2—leprosy	0.00423	0.0417	CbGpPWpGaD
Vorinostat—Acute coronary syndrome—Thalidomide—leprosy	0.00421	0.0141	CcSEcCtD
Vorinostat—Body temperature increased—Dapsone—leprosy	0.00421	0.014	CcSEcCtD
Vorinostat—Myocardial infarction—Thalidomide—leprosy	0.00419	0.014	CcSEcCtD
Vorinostat—Oedema peripheral—Thalidomide—leprosy	0.00378	0.0126	CcSEcCtD
Vorinostat—Chills—Thalidomide—leprosy	0.00344	0.0115	CcSEcCtD
Vorinostat—Alopecia—Thalidomide—leprosy	0.00339	0.0113	CcSEcCtD
Vorinostat—Vomiting—Dapsone—leprosy	0.00338	0.0113	CcSEcCtD
Vorinostat—Headache—Dapsone—leprosy	0.00333	0.0111	CcSEcCtD
Vorinostat—Dysgeusia—Thalidomide—leprosy	0.00327	0.0109	CcSEcCtD
Vorinostat—Muscle spasms—Thalidomide—leprosy	0.00321	0.0107	CcSEcCtD
Vorinostat—HDAC1—p75 NTR receptor-mediated signalling—RIPK2—leprosy	0.00317	0.0313	CbGpPWpGaD
Vorinostat—Nausea—Dapsone—leprosy	0.00316	0.0106	CcSEcCtD
Vorinostat—Anaemia—Thalidomide—leprosy	0.00308	0.0103	CcSEcCtD
Vorinostat—Angioedema—Thalidomide—leprosy	0.00305	0.0102	CcSEcCtD
Vorinostat—NCOR1—Regulation of nuclear SMAD2/3 signaling—IL10—leprosy	0.00301	0.0297	CbGpPWpGaD
Vorinostat—Syncope—Thalidomide—leprosy	0.00299	0.01	CcSEcCtD
Vorinostat—Leukopenia—Thalidomide—leprosy	0.00299	0.00998	CcSEcCtD
Vorinostat—Loss of consciousness—Thalidomide—leprosy	0.00293	0.0098	CcSEcCtD
Vorinostat—Cough—Thalidomide—leprosy	0.00291	0.00973	CcSEcCtD
Vorinostat—Chest pain—Thalidomide—leprosy	0.00284	0.00949	CcSEcCtD
Vorinostat—Dry mouth—Thalidomide—leprosy	0.00278	0.00928	CcSEcCtD
Vorinostat—Infection—Thalidomide—leprosy	0.00271	0.00904	CcSEcCtD
Vorinostat—Shock—Thalidomide—leprosy	0.00268	0.00895	CcSEcCtD
Vorinostat—Thrombocytopenia—Thalidomide—leprosy	0.00267	0.00891	CcSEcCtD
Vorinostat—NCOR1—Notch-mediated HES/HEY network—CD4—leprosy	0.00264	0.0261	CbGpPWpGaD
Vorinostat—Anorexia—Thalidomide—leprosy	0.0026	0.00867	CcSEcCtD
Vorinostat—HDAC1—Regulation of nuclear SMAD2/3 signaling—IL10—leprosy	0.00245	0.0242	CbGpPWpGaD
Vorinostat—HDAC11—Signaling events mediated by HDAC Class I—TNF—leprosy	0.00238	0.0235	CbGpPWpGaD
Vorinostat—Decreased appetite—Thalidomide—leprosy	0.00237	0.00791	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Thalidomide—leprosy	0.00235	0.00785	CcSEcCtD
Vorinostat—Fatigue—Thalidomide—leprosy	0.00235	0.00784	CcSEcCtD
Vorinostat—Constipation—Thalidomide—leprosy	0.00233	0.00778	CcSEcCtD
Vorinostat—HDAC4—Cardiac Hypertrophic Response—TNF—leprosy	0.00219	0.0216	CbGpPWpGaD
Vorinostat—HDAC9—SIDS Susceptibility Pathways—IL10—leprosy	0.00216	0.0213	CbGpPWpGaD
Vorinostat—Body temperature increased—Thalidomide—leprosy	0.00215	0.00719	CcSEcCtD
Vorinostat—HDAC1—Notch-mediated HES/HEY network—CD4—leprosy	0.00215	0.0212	CbGpPWpGaD
Vorinostat—HDAC2—p75 NTR receptor-mediated signalling—RIPK2—leprosy	0.00204	0.0202	CbGpPWpGaD
Vorinostat—HDAC6—Signaling events mediated by HDAC Class I—TNF—leprosy	0.002	0.0197	CbGpPWpGaD
Vorinostat—Asthenia—Thalidomide—leprosy	0.00195	0.00653	CcSEcCtD
Vorinostat—Pruritus—Thalidomide—leprosy	0.00193	0.00644	CcSEcCtD
Vorinostat—HDAC9—Cardiac Hypertrophic Response—TNF—leprosy	0.00189	0.0187	CbGpPWpGaD
Vorinostat—Diarrhoea—Thalidomide—leprosy	0.00186	0.00622	CcSEcCtD
Vorinostat—HDAC4—Signaling events mediated by HDAC Class I—TNF—leprosy	0.00181	0.0178	CbGpPWpGaD
Vorinostat—Dizziness—Thalidomide—leprosy	0.0018	0.00602	CcSEcCtD
Vorinostat—Vomiting—Thalidomide—leprosy	0.00173	0.00578	CcSEcCtD
Vorinostat—Headache—Thalidomide—leprosy	0.00171	0.0057	CcSEcCtD
Vorinostat—HDAC8—Signaling events mediated by HDAC Class I—TNF—leprosy	0.00167	0.0164	CbGpPWpGaD
Vorinostat—NCOR1—C-MYB transcription factor network—CD4—leprosy	0.00166	0.0164	CbGpPWpGaD
Vorinostat—HDAC1—Regulation of Telomerase—IFNG—leprosy	0.00166	0.0164	CbGpPWpGaD
Vorinostat—Nausea—Thalidomide—leprosy	0.00162	0.0054	CcSEcCtD
Vorinostat—HDAC2—Regulation of nuclear SMAD2/3 signaling—IL10—leprosy	0.00158	0.0156	CbGpPWpGaD
Vorinostat—HDAC1—TWEAK Signaling Pathway—TNF—leprosy	0.00158	0.0156	CbGpPWpGaD
Vorinostat—HDAC4—MicroRNAs in cardiomyocyte hypertrophy—TNF—leprosy	0.00156	0.0154	CbGpPWpGaD
Vorinostat—HDAC9—Signaling events mediated by HDAC Class I—TNF—leprosy	0.00156	0.0154	CbGpPWpGaD
Vorinostat—HDAC3—Signaling by NGF—RIPK2—leprosy	0.00156	0.0154	CbGpPWpGaD
Vorinostat—HDAC1—Regulation of Telomerase—IL2—leprosy	0.00147	0.0145	CbGpPWpGaD
Vorinostat—HDAC1—SIDS Susceptibility Pathways—IL10—leprosy	0.00145	0.0143	CbGpPWpGaD
Vorinostat—HDAC1—Glucocorticoid receptor regulatory network—IFNG—leprosy	0.00143	0.0141	CbGpPWpGaD
Vorinostat—HDAC3—Signaling events mediated by HDAC Class I—TNF—leprosy	0.0014	0.0138	CbGpPWpGaD
Vorinostat—HDAC9—MicroRNAs in cardiomyocyte hypertrophy—TNF—leprosy	0.00135	0.0133	CbGpPWpGaD
Vorinostat—HDAC1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—leprosy	0.00131	0.0129	CbGpPWpGaD
Vorinostat—HDAC3—Transcriptional regulation of white adipocyte differentiation—TNF—leprosy	0.0013	0.0128	CbGpPWpGaD
Vorinostat—NCOR1—Signaling events mediated by HDAC Class I—TNF—leprosy	0.00129	0.0127	CbGpPWpGaD
Vorinostat—HDAC1—Glucocorticoid receptor regulatory network—IL2—leprosy	0.00127	0.0125	CbGpPWpGaD
Vorinostat—NCOR1—Transcriptional regulation of white adipocyte differentiation—TNF—leprosy	0.00119	0.0118	CbGpPWpGaD
Vorinostat—HDAC1—Signaling by NGF—RIPK2—leprosy	0.00117	0.0115	CbGpPWpGaD
Vorinostat—HDAC11—Disease—SLC11A1—leprosy	0.00111	0.011	CbGpPWpGaD
Vorinostat—HDAC2—Regulation of Telomerase—IFNG—leprosy	0.00107	0.0105	CbGpPWpGaD
Vorinostat—HDAC1—Signaling events mediated by HDAC Class I—TNF—leprosy	0.00105	0.0104	CbGpPWpGaD
Vorinostat—HDAC2—Regulation of Telomerase—IL2—leprosy	0.00095	0.00937	CbGpPWpGaD
Vorinostat—HDAC6—Disease—SLC11A1—leprosy	0.000934	0.00922	CbGpPWpGaD
Vorinostat—HDAC2—Glucocorticoid receptor regulatory network—IFNG—leprosy	0.00092	0.00908	CbGpPWpGaD
Vorinostat—HDAC4—Disease—SLC11A1—leprosy	0.000845	0.00834	CbGpPWpGaD
Vorinostat—HDAC9—SIDS Susceptibility Pathways—TNF—leprosy	0.000821	0.0081	CbGpPWpGaD
Vorinostat—HDAC2—Glucocorticoid receptor regulatory network—IL2—leprosy	0.000818	0.00807	CbGpPWpGaD
Vorinostat—NCOR1—Adipogenesis—TNF—leprosy	0.000784	0.00774	CbGpPWpGaD
Vorinostat—HDAC8—Disease—SLC11A1—leprosy	0.00078	0.00769	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—RIPK2—leprosy	0.000752	0.00742	CbGpPWpGaD
Vorinostat—HDAC8—Integrated Pancreatic Cancer Pathway—TNF—leprosy	0.000747	0.00737	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—SDHD—leprosy	0.00073	0.0072	CbGpPWpGaD
Vorinostat—HDAC9—Disease—SLC11A1—leprosy	0.000729	0.0072	CbGpPWpGaD
Vorinostat—HDAC2—Signaling events mediated by HDAC Class I—TNF—leprosy	0.000676	0.00667	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—SDHD—leprosy	0.000671	0.00662	CbGpPWpGaD
Vorinostat—HDAC3—Disease—SLC11A1—leprosy	0.000655	0.00647	CbGpPWpGaD
Vorinostat—NCOR1—Disease—SLC11A1—leprosy	0.000602	0.00594	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—RIPK2—leprosy	0.000569	0.00562	CbGpPWpGaD
Vorinostat—HDAC1—SIDS Susceptibility Pathways—TNF—leprosy	0.000553	0.00545	CbGpPWpGaD
Vorinostat—HDAC1—Disease—SLC11A1—leprosy	0.000491	0.00484	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—RIPK2—leprosy	0.000477	0.00471	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—RIPK2—leprosy	0.000431	0.00426	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—RIPK2—leprosy	0.000398	0.00393	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—RIPK2—leprosy	0.000372	0.00367	CbGpPWpGaD
Vorinostat—HDAC11—Disease—CD4—leprosy	0.000354	0.00349	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—RIPK2—leprosy	0.000334	0.0033	CbGpPWpGaD
Vorinostat—HDAC2—Disease—SLC11A1—leprosy	0.000316	0.00312	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—RIPK2—leprosy	0.000307	0.00303	CbGpPWpGaD
Vorinostat—HDAC6—Disease—CD4—leprosy	0.000296	0.00293	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—IL2—leprosy	0.000296	0.00292	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—TNF—leprosy	0.000293	0.00289	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—TNF—leprosy	0.00027	0.00266	CbGpPWpGaD
Vorinostat—HDAC4—Disease—CD4—leprosy	0.000268	0.00265	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—RIPK2—leprosy	0.00025	0.00247	CbGpPWpGaD
Vorinostat—HDAC8—Disease—CD4—leprosy	0.000247	0.00244	CbGpPWpGaD
Vorinostat—HDAC9—Disease—CD4—leprosy	0.000231	0.00228	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—IL2—leprosy	0.000228	0.00225	CbGpPWpGaD
Vorinostat—HDAC3—Disease—CD4—leprosy	0.000208	0.00205	CbGpPWpGaD
Vorinostat—NCOR1—Disease—CD4—leprosy	0.000191	0.00189	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—IL2—leprosy	0.000191	0.00188	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—IL2—leprosy	0.000191	0.00188	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—IL2—leprosy	0.000173	0.0017	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—RIPK2—leprosy	0.000161	0.00159	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—IL2—leprosy	0.000159	0.00157	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CD4—leprosy	0.000156	0.00154	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—IL2—leprosy	0.000149	0.00147	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IL2—leprosy	0.000134	0.00132	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IL2—leprosy	0.000123	0.00121	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CD4—leprosy	0.0001	0.00099	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IL2—leprosy	0.0001	0.00099	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IL2—leprosy	6.46e-05	0.000638	CbGpPWpGaD
